425 filed Jul 23, 2026 at 06:11 ET
Gentherm reported record Q2 2026 revenue of $416.2M, up 11.0% YoY (9.5% ex-FX), and raised full-year 2026 guidance for revenue, Adjusted EBITDA, and free cash flow. The Board also authorized a new $400M stock repurchase program, replacing the prior $150M program. The company completed the acquisition of Innovative Medical Equipment, LLC and confirmed the Modine Performance Technologies combination remains on track for early Q4 2026. However, GAAP operating income declined sharply to $10.7M from $24.0M due to elevated restructuring and M&A expenses, and operating cash flow fell to $2.3M from $31.7M, tempering the headline revenue beat.